CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Current Pharmaceutical Biotechnology (ISSN 1389-2010) is an international peer-reviewed journal published by Bentham Science Publishers in the United Arab Emirates, dedicated to advancing research in pharmaceutical biotechnology. Appearing monthly, the journal covers a broad spectrum of interdisciplinary topics, including drug development, biotechnological applications, gene therapy, nanomedicine, and biopharmaceuticals, with a particular emphasis on the integration of technological innovation and clinical translation. Indexed in the Science Citation Index (SCI), the publication maintains an impact factor generally ranging between 2 and 3 in recent years and is typically categorized in the third or fourth quartile of the Chinese Academy of Sciences (CAS) journal ranking within the medical or biological engineering fields. As a non-open access publication, it serves a global audience of researchers and professionals engaged in pharmaceutical biotechnology, offering a stable platform for disseminating high-quality scientific findings while requiring authors to consider its commercial publishing model, including potential review timelines and publication fees, when selecting a venue for their work.